Mopping Up Excess Chemotherapy Drugs
Mopping Up Excess Chemotherapy Drugs
A prototype in-vein device would collect toxic medications before they reach healthy tissues.
Mopping Up Excess Chemotherapy Drugs
Mopping Up Excess Chemotherapy Drugs

A prototype in-vein device would collect toxic medications before they reach healthy tissues.

A prototype in-vein device would collect toxic medications before they reach healthy tissues.

chemotherapy
Infographic: Medication Mop-Up
Infographic: Medication Mop-Up
Ruth Williams | Apr 1, 2019
Researchers have developed a prototype device to filter excess chemotherapy medication from the bloodstream.
From Chemical Weapon to Chemotherapy, 1917–1946
From Chemical Weapon to Chemotherapy, 1917–1946
Carolyn Wilke | Apr 1, 2019
Mustard gas blistered men’s bodies on the battlefield, but paved the way for cancer-fighting drugs.
Exosomes Linked to Cancer Spread from Chemoresistant Tumors in Mice
Exosomes Linked to Cancer Spread from Chemoresistant Tumors in Mice
Carolyn Wilke | Jan 10, 2019
The vesicles promote metastasis after chemotherapy, but the authors say the results shouldn’t alarm patients and may point to ways to improve treatments.
Leukemia Relapses May Arise From Specialized Cells
Leukemia Relapses May Arise From Specialized Cells
Sukanya Charuchandra | Dec 1, 2018
Targeting the transient group of cells could prevent recurrence of the disease.
Drug Cocktail Slows Progress of Aggressive Breast Cancer
Drug Cocktail Slows Progress of Aggressive Breast Cancer
Ashley P. Taylor | Oct 22, 2018
Checkpoint inhibition combined with chemotherapy gives patients with triple-negative metastatic breast cancer about two months more time without significant tumor growth, a study finds.
A Radical Intervention, 1894
A Radical Intervention, 1894
Catherine Offord | Apr 1, 2018
William Halsted’s approach to mastectomy took the medical world by storm at the turn of the last century.
Mutant RAS Proteins Team Up for Oncogenicity
Mutant RAS Proteins Team Up for Oncogenicity
Jim Daley | Apr 1, 2018
Mice with cancer whose KRAS proteins couldn’t link together had much better survival outcomes than those whose oncogenic mutant paired with wild-type KRAS.
Researchers Getting Smarter About Pairing Cancer Treatments
Researchers Getting Smarter About Pairing Cancer Treatments
Anna Azvolinsky | Apr 1, 2018
Multidrug combinations lead to better results for cancer patients, but efficiently identifying them is proving difficult.
New CAR T-Cell Therapy Shows Promise in Trial for Leukemia
New CAR T-Cell Therapy Shows Promise in Trial for Leukemia
Katarina Zimmer | Nov 21, 2017
The immunotherapy, which targets CD22 on cancer cells rather than CD19, might prove useful in patients for whom previous T-cell treatments were unsuccessful.